Microplastics evidence audit table

Plastic in brain / 6 g brain claim

Nihart 2025; Rauert 2025; Clough 2026; Mohamed Nor 2021

Reported polymer-associated signals in human brain samples and high estimated values in the disputed claim.

Did not conclusively prove intact plastic particles in brain tissue, grams of plastic, or harm.

Py-GC/MS can be affected by lipid-rich biological matrices; contamination and mass-plausibility problems; claimed mass conflicts with lifetime exposure estimates.

Not proved; mass-balance conflict

Particles or polymer signals in blood

Wu 2023; Brits 2024; Leslie 2022; Rauert 2025; Guan 2023

Reported particles, pigments, or polymer-associated signals in blood; Wu reported plastic as a small fraction of detected particles.

Did not prove disease, toxicity, accumulation, or that Py-GC/MS signals were intact circulating plastic particles.

Very small amounts; contamination risk; Py-GC/MS destroys the sample; method-dependent results.

Detection only; weak for harm

Bottled-water nanoplastics

Qian 2024; Materic 2024; Qian Reply 2024; Juengling 2026; Ruggeri 2025

Reported high particle counts in bottled water using stimulated Raman scattering; later work addresses method challenges.

Did not prove bottled water is dangerous or causes disease; high-count result has not been established as routine exposure.

New method; blank/control debate; particle count rather than risk; very small estimated mass.

Method-limited detection; weak for risk

Credit-card-per-week exposure claim

Cox 2019; Senathirajah 2021; Welle 2018; Mohamed Nor 2021

Earlier exposure models produced public claims of large intake; later mass-based analyses give much lower context.

Does not prove people ingest grams per week; does not fit mass-based exposure or retention estimates.

Particle-to-mass assumptions and overinterpretation; conflicts with later mass-based estimates.

Unsupported / contradicted

Lifetime intake and retained burden

Mohamed Nor 2021

Estimated adult intake about 583 ng/day, about 0.015 g over 70 years before elimination, and nanogram-scale retained burden.

Does not prove exact intake for every individual or every exposure scenario.

Model depends on available exposure data and assumptions, but gives strong mass-scale context.

Strong for dose context

High-dose laboratory harm studies

Lenz 2016; Gouin 2022; Koelmans 2019; Eberhard 2024; Burns 2018

Many studies use exposure concentrations far above measured environmental or human exposure.

Do not prove normal human exposure causes harm.

Dose is often hundreds, thousands, or millions of times too high; many studies use artificial particles.

Useful for hazard screening; weak for real-world risk

Artificial polystyrene bead studies

Lenz 2016; Hartmann 2019; Gigault 2021; Gouin 2022

Often use uniform laboratory beads because they are convenient and measurable.

Do not prove effects from real-world mixed plastic particles at realistic exposure.

Particle type, shape, size, surface, and dose often do not match environmental exposure.

Weak for human risk

Blood-brain barrier crossing claim

Kopatz 2023; Lenz 2016; Shan 2022; Semmler-Behnke 2008

Reported that lab-made polystyrene nanoparticles can cross biological barriers under experimental conditions.

Does not prove environmental nanoplastics cross the human BBB at normal exposure levels.

Artificial particles, forced exposure, and extreme dose relative to realistic exposure.

Weak for real-world human risk

Heart attacks / strokes / atheromas

Marfella 2024; Bradford Hill 1965; Koelmans 2022

Reported an association between polymer-associated material in plaques and later cardiovascular events.

Did not prove plastic caused plaque, heart attacks, strokes, or death.

Association, not causation; possible confounding; detection method and particle-identity questions.

Association only; causation not proved

Placenta / fetal exposure claims

Ragusa 2021; Liu 2023; Zhu 2023; Bongaerts 2020; Clough 2026

Reported particles or plastic-associated findings in placenta or related samples.

Did not prove fetal harm, developmental disease, or reliable body-wide accumulation.

Small samples; contamination sensitivity; variable methods; particle identity and blanks often disputed.

Detection only; harm not proved

Lung tissue findings

Jenner 2022; Amato-Lourenco 2021; Wieland 2022; Vianello 2019

Reported particles in lung tissue or airborne exposure; lung exposure route is biologically plausible.

Does not prove disease, toxic effect, or systemic accumulation.

Contamination/blank correction and quantification issues; plastic must be compared with total inhaled dust.

Moderate for detection; weak for harm

Stool findings / elimination

Schwabl 2019; Zhang 2021; Mohamed Nor 2021

Reported particles in stool and modeled very low retained burden.

Does not prove accumulation or harm.

Stool detection mainly shows ingestion and excretion; analytical methods vary.

Moderate to strong for elimination context

Tea-bag particle release

Hernandez 2019; EFSA 2025

Reported particle release from some polymer-containing tea bags under hot-water conditions.

Did not prove harm to consumers.

Method limitations, particle-count emphasis, solubles/precipitate issues, and missing dose-risk context.

Release detection only; weak for risk

Plastic cutting boards

Yadav 2023; EFSA 2025; IARC 1995

Reported particles can be released during cutting or scraping.

Did not prove normal cutting-board use causes disease or meaningful exposure risk.

Particle count and estimated mass need context; hygiene and alternative-material risks must be compared.

Release possible; weak for health risk

Drinking-water occurrence and treatment

WHO 2019; Koelmans 2019; Pivokonsky 2018; Pivokonsky 2020; Velasco 2022; Velasco 2023; Mintenig 2019; Juengling 2026; Yang 2024; Gambino 2022

Microplastics can be detected in some drinking water; treatment removes many particles; plastic may be a small minority of total particles.

Does not prove health risk from tap or bottled water.

Methods vary; size cutoffs differ; particle count often lacks mass and toxicity context.

Moderate for occurrence; weak for risk

Drinking-water distribution pipes are a net source of microplastics to household tap water

Sun 2024; Feld 2021

Sun found fewer microplastics in household tap water than in treated water leaving the plant, suggesting the distribution system was not a net contributor. Feld found very low confirmed microplastic levels in 17 Danish tap-water samples, with no PE or PVC particles confirmed.

Did not prove that pipes can never release any particles under any condition. Did not directly trace every particle to or away from a specific pipe material. Feld did not measure treated-water input versus household-water output.

Sun used 1 L samples and a 20 um cutoff; results may not apply to all systems, pipe ages, water chemistries, or operating conditions. Feld had strong QA/QC but reported very low levels near or below detection/background and was not a direct pipe-release experiment.

Moderate evidence against pipes being a net source; strong evidence against necessary PE/PVC release under normal conditions

Ocean fiber composition

Suaria 2020

Global surface-water fiber analysis found about 8% synthetic fibers and about 92% natural fibers.

Does not prove all ocean particles everywhere have the same composition or that fibers are harmful.

Surface-water fiber dataset; not a complete inventory of all marine debris.

Strong for fiber-composition context

Ocean ecological risk

Beiras 2020; Jovanovic 2018; GESAMP 2016; FAO 2017

Reviewed or tested risks and found currently monitored microplastics pose negligible or limited demonstrated risk under realistic conditions.

Does not prove no possible effect under every species, particle type, or local pollution condition.

Ecological risk varies by exposure, species, particle type, and local conditions.

Moderate to strong for current monitored risk

Dust exposure context

Mohamed Nor 2021; Wieland 2022; Vianello 2019; Yakovenko 2025; Eberhard 2024

Plastic appears to be a small fraction of indoor and outdoor particles compared with mineral dust, cellulose, protein, soot, skin particles, and other material.

Does not prove every dust environment has the same composition.

Dust composition varies by setting and method; exposure is often reported by count rather than mass.

Strong for comparative context

Chemical-vector claim

Koelmans 2016; Koelmans 2022; Bakir 2014; Teuten 2009; Beiras 2018; Beiras 2019; Ziajahromi 2019

Plastics can sorb chemicals in principle; several studies show vector effects are often negligible or can reduce bioavailability.

Does not prove microplastics are an important chemical-delivery pathway for humans at normal exposure.

Chemical dose from particles is tiny compared with direct exposure pathways; context often missing.

Strong against major human vector risk

Additives vs microplastic particles

Hahladakis 2018; EFSA 2025; FDA 2024; Lithner 2011

Additives, monomers, leachables, and particles are different categories that require separate evidence.

A chemical claim does not automatically prove particle toxicity.

Public and media often conflate particles with additives or unrelated chemicals.

Strong conceptual distinction

Alternatives to plastic

Meng 2024; Voulvoulis 2019; Franklin Associates 2018; Simantris 2024; Reimann 2010; Krachler 2009; Turner 2019

Many plastic replacements increase material use, emissions, weight, breakage, waste, or other impacts.

Does not prove plastic is best in every application.

LCA is application-specific; substitution must compare full systems.

Strong for substitution caution

Agency risk conclusions

WHO 2019; WHO 2022; FDA 2024; EFSA 2016; EFSA 2025; EPA 2026; FSSAI 2024

Major agencies call for better methods and data and do not conclude that normal exposure is a proven health crisis.

Does not mean research should stop or that every exposure scenario is fully characterized.

Measurement science is still developing; agencies use cautious language.

Strong for current policy context